Pilot Study of Growth Hormon to Treat SMA Typ II and III

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

August 31, 2011

Conditions
Muscular Atrophy, Spinal
Interventions
DRUG

somatotropin

0,015 mg/kg/d as one dose s.c. in the evening over one week followed by a 11 week period with 0,03 mg/kg/d s.c. as one dose in the evening

DRUG

Placebo

0,015 mg/kg/d as one dose s.c. in the evening over one week followed by a 11 week period with 0,03 mg/kg/d s.c. as one dose in the evening

Trial Locations (6)

13353

Charité, Department of Neurpaediatrics, Berlin

24105

University Children'S Hospital, Kiel

37075

University Children'S Hospital, Göttingen

45122

University Children'S Hospital, Essen

55110

University Children'S Hospital, Mainz

80337

von Haunersches Kinderspital, Munich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

University Hospital Freiburg

OTHER